Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 13, 2024

BUY
$191.17 - $325.63 $715,549 - $1.22 Million
3,743 New
3,743 $1.22 Million
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $116,395 - $155,943
723 Added 19.0%
4,528 $862,000
Q3 2023

Nov 13, 2023

BUY
$194.33 - $283.97 $59,853 - $87,462
308 Added 8.81%
3,805 $757,000
Q2 2023

Aug 08, 2023

SELL
$223.05 - $302.68 $273,905 - $371,691
-1,228 Reduced 25.99%
3,497 $998,000
Q1 2023

May 12, 2023

SELL
$175.41 - $217.92 $9,647 - $11,985
-55 Reduced 1.15%
4,725 $1.02 Million
Q4 2022

Feb 08, 2023

BUY
$204.38 - $296.82 $24,934 - $36,212
122 Added 2.62%
4,780 $982,000
Q3 2022

Oct 27, 2022

SELL
$195.21 - $310.53 $697,290 - $1.11 Million
-3,572 Reduced 43.4%
4,658 $1.3 Million
Q2 2022

Aug 08, 2022

SELL
$115.91 - $214.48 $3,940 - $7,292
-34 Reduced 0.41%
8,230 $1.57 Million
Q1 2022

May 04, 2022

SELL
$127.96 - $207.36 $25,847 - $41,886
-202 Reduced 2.39%
8,264 $1.71 Million
Q4 2021

Feb 10, 2022

BUY
$165.13 - $241.83 $387,725 - $567,816
2,348 Added 38.38%
8,466 $1.51 Million
Q3 2021

Nov 12, 2021

BUY
$163.99 - $235.57 $145,459 - $208,950
887 Added 16.96%
6,118 $1.26 Million
Q2 2021

Aug 12, 2021

SELL
$131.45 - $201.49 $190,339 - $291,757
-1,448 Reduced 21.68%
5,231 $992,000
Q1 2021

May 06, 2021

BUY
$92.73 - $142.05 $194,918 - $298,589
2,102 Added 45.93%
6,679 $870,000
Q4 2020

Feb 12, 2021

BUY
$67.44 - $103.72 $308,672 - $474,726
4,577 New
4,577 $475,000
Q3 2020

Nov 04, 2020

SELL
$42.79 - $75.8 $240,993 - $426,905
-5,632 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$27.25 - $47.53 $153,472 - $267,688
5,632 New
5,632 $267,000
Q1 2020

May 15, 2020

SELL
$23.16 - $47.74 $120,130 - $247,627
-5,187 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$29.4 - $44.98 $152,497 - $233,311
5,187 New
5,187 $228,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.